SCM
DRUG

Sio Capital Management’s Bright Minds Biosciences DRUG Stock Holding History

Sio Capital Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.19M Sell
73,952
-12,131
-14% -$953K 0.86% 37
2026
Q1 		$6.28M Buy
86,083
+4,200
+5% +$338K 0.9% 37
2025
Q4 		$6.39M Sell
81,883
-108,881
-57% -$7.28M 1.01% 27
2025
Q3 		$11.6M Sell
190,764
-321,574
-63% -$12.5M 2.93% 13
2025
Q2 		$13.4M Buy
512,338
+4,776
+0.9% +$143K 5.11% 6
2025
Q1 		$18.3M Buy
507,562
+55,769
+12% +$2.04M 5.45% 7
2024
Q4 		$16.3M Buy
+451,793
New +$15.9M 4.58% 7

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sio Capital Management's DRUG Position: Q2 2026 in Review

Sio Capital Management reduced its Bright Minds Biosciences (DRUG) stake by 14% in Q2 2026, selling an estimated $953K and leaving 73,952 shares worth $5.19M. The position accounts for 0.86% of the portfolio, ranked #37.

Sio Capital Management first reported a position in DRUG in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.3M in Q1 2025. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Sio Capital Management held 73,952 shares of Bright Minds Biosciences worth $5.19M as of Q2 2026.
  • Sio Capital Management sold 12,131 Bright Minds Biosciences shares in Q2 2026, an estimated $953K.
  • Bright Minds Biosciences made up 0.86% of Sio Capital Management's portfolio in Q2 2026, its #37 holding.
  • Sio Capital Management first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Sio Capital Management's Bright Minds Biosciences position peaked at $18.3M in Q1 2025.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.